ºÐ°ú | ½Ã°£ | ±³À°ÁÖÁ¦ | ¼Ò¼Ó | °»ç¸í |
³»ºÐºñ ´ë »ç |
Update on Osteoporosis | <ÁÂÀå: À±Çö±¸, º¯µ¿¿ø> |
|
09:00~09:40 |
Assessment of fracture risk |
°æÈñÀÇ´ë |
±è´öÀ± |
09:40~10:20 |
Nutritional supplementation for osteoporosis (calcium and vitamin D) |
¿¬¼¼ÀÇ´ë |
ÀÌÀ¯¹Ì |
10:40~11:20 |
Long term efficacy and safety of anti-resorptive therapy |
°æÈñÀÇ´ë |
Á¤È£¿¬ |
11:20~12:00 |
Pros and cons of vertebroplasty and/or kyphoplasty for vertebral fractrue |
À»ÁöÀÇ´ë |
±èȯÁ¤ |
Ç÷ ¾× Á¾ ¾ç |
Consultative Hematology | <ÁÂÀå: ¹Ú¼±¾ç> |
|
09:00~09:20 |
Anemia and erythrocytosis in surgical patients |
´ë±¸ÆÄƼ¸¶º´¿ø |
ÀÌÁ¤¸² |
09:20~09:40 |
Management of bleeding disorders in surgical patients |
ÇѸ²ÀÇ´ë |
±èÈ¿Á¤ |
09:40~10:00 |
Prevention and treatment of thrombotic disorders in surgical patients |
ºÎ»êÀÇ´ë |
½ÅÈ£Áø |
10:00~10:20 |
Hematologic problems in pregnancy |
´ë±¸°¡Å縯ÀÇ´ë |
·ùÇå¸ð |
Consultative Oncology | <ÁÂÀå: ³ëÀç°æ> |
|
10:40~11:00 |
Special considerations in surgery of cancer patients |
Àü³²ÀÇ´ë |
Á¤ÀÍÁÖ |
11:00~11:20 |
Resection of metastatic disease |
ÃæºÏÀÇ´ë |
À̱âÇü |
11:20~11:40 |
Management of cancer-associated complications |
ÇѾçÀÇ´ë |
ÃÖÁ¤Çý |
11:40~12:00 |
Thrombotic complications in cancer patients |
¼¿ïÀÇ´ë |
¹æ¼ö¹Ì |
°¨ ¿° |
¼ºÀÎÀÇ ¿¹¹æÁ¢Á¾ |
09:00~09:40 |
ÀÎÇ÷翣ÀÚ |
°í·ÁÀÇ´ë |
Á¤ÈñÁø |
09:40~10:20 |
Æó·Å¾Ë±Õ |
¼º±Õ°üÀÇ´ë |
¿À¿ø¼· |
10:40~11:20 |
¼ö¸·¾Ë±Õ |
°æÈñÀÇ´ë |
ÀÌ»ó¿À |
11:20~12:00 |
ÆÄ»ódz/µðÇÁÅ׸®¾Æ |
°¡Å縯ÀÇ´ë |
ÃÖÁ¤Çö |
¾Ë ·¹ ¸£ ±â |
Recent Update of Allergy |
09:00~09:30 |
Hypereosinophilia ȯÀÚÀÇ Á¢±Ù |
°¡ÃµÀÇ´ë |
ÀÌ»óÇ¥ |
09:30~10:00 |
Pharmacogenetics in aspirin allergy |
¼øõÇâÀÇ´ë |
Àå¾È¼ö |
10:00~10:30 |
¸¸¼º±âħ |
¼¿ïÀÇ´ë |
ÀåÀ±¼® |
11:00~11:30 |
Asthma¿¡¼ÀÇ VEGF |
ÀüºÏÀÇ´ë |
ÀÌ¿ëö |
11:30~12:00 |
¾Ë·¹¸£±â Áúȯ¿¡¼ÀÇ ¸é¿ªÄ¡·áÀÇ ¿øÄ¢ |
¿¬¼¼ÀÇ´ë |
¹ÚÁß¿ø |
·ù ¸¶ Ƽ ½º |
Àü½ÅÈ«¹Ý¼º·çǪ½ºÀÇ ÃÖ½ÅÁö°ß |
09:00~09:30 |
Genetics of SLE |
°í·ÁÀÇ´ë |
ÀÌ¿µÈ£ |
09:30~10:00 |
Autoantibodies in SLE |
À»ÁöÀÇ´ë |
½É½Âö |
10:00~10:30 |
Premature atherosclerotic disease in SLE |
Æ÷õÁß¹®ÀÇ´ë |
ÃÖÁøÁ¤ |
10:50~11:25 |
Infections and SLE |
¾ÆÁÖÀÇ´ë |
¼Ã¢Èñ |
11:25~11:55 |
Newer therapeutic approaches for SLE |
ÀÌÈÀÇ´ë |
ÀÌÁö¼ö |